Launch week offerEnds in00h00m00s

annual Promonthly Pro

Sanil Bhatia

Group Leader

Heinrich Heine University Düsseldorf

Germany

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Germany Professors in Cell Biology Cell Biology professors in Germany

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (16)

Christoph Hieber

Johannes Gutenberg Universität Mainz

GERMANY

View details

Andrea Hanel

University of Eastern Finland

FINLAND

View details

Thomas Kurz

Heinrich Heine University Düsseldorf

GERMANY

View details

Oliver H. Krämer

Prof. Dr

University Medical Center of the Johannes Gutenberg University Mainz

GERMANY

View details

Jolanda Sarno

Ricercatori a tempo determinato

University of Milano-Bicocca

ITALY

View details

Claire G Salter

Academic Clinical Lecturer

University of Southampton

UNITED KINGDOM

View details

Finn Kristian Hansen

University of Bonn

GERMANY

View details

Manuel Etzkorn

Heinrich Heine University Düsseldorf

GERMANY

View details

Sabine Strehl

Group leader

St. Anna Children's Cancer Research Institute

AUSTRIA

View details

Silvia von Karstedt

Principle Investigator

University of Cologne

GERMANY

View details

Vanna Denti

Ricercatori a tempo determinato

University of Milano-Bicocca

ITALY

View details

Maxmilian Seidl

University Hospital Düsseldorf

GERMANY

View details

Karina Stephanie Krings

Heinrich Heine University Düsseldorf

GERMANY

View details

Anke Katharina Bergmann

Director, Chair

University Hospital Würzburg

GERMANY

View details

hans neubauer

Head of Research (Prof. Dr. rer. nat. [W2])

Heinrich Heine University Düsseldorf

GERMANY

View details

christoph peter

Heinrich Heine University Düsseldorf

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sanil Bhatia

Research Interests

Make your next move.

Explore related searches

Articles (20)

Measurable Residual Disease-Dependent Unfavorable Outcomes in Pediatric PAX5-Rearranged B-Acute Lymphoblastic Leukemia

NK cell immunosurveillance and CX3CL1-CX3CR1 axis perturbations in ETV6::RUNX1 positive preleukemia and BCP-ALL

Rapid Two-Step Multicomponent Synthesis and Structure-degradation Relationships of Selective HDAC6 PROTAC Degraders

Targeting Histone Acetyltransferases EP300/CBP by Novel Proline-Based PROTAC Degraders

Efficacy of the kinase inhibitor CHZ868 against JAK2 rearrangements in pediatric acute lymphoblastic leukemia

Epigenetic remodeling via HDAC6 inhibition amplifies anti-tumoral immune responses in myeloid leukemia cells

Discovery of Histone Deacetylase 8-Specific Proteolysis-Targeting Chimeras with Anticancer Activity against Hematological Malignancies.

H1‐0 is a specific mediator of the repressive ETV6::RUNX1 transcriptional landscape in preleukemia and B cell acute lymphoblastic leukemia

Pharmacological Inhibition of MDM2 Induces Apoptosis in p53-Mutated Triple-Negative Breast Cancer

The protein deacetylase HDAC10 controls DNA replication in malignant lymphoid cells

Immune training enhances anti-viral responses and improves outcomes in Pax5−/+ mice susceptible to chronic infection

Deep transfer learning approach for automated cell death classification reveals novel ferroptosis-inducing agents in subsets of B-ALL

Small-molecule inhibitor of C‑terminal HSP90 dimerization modulates autophagy and functions synergistically with mTOR inhibition to kill cisplatin-resistant cancer cells.

Identification of non-charged 7.44 analogs interacting with the NHR2 domain of RUNX1-ETO with improved antiproliferative effect in RUNX-ETO positive cells

Novel meriolin derivatives potently inhibit cell cycle progression and transcription in leukemia and lymphoma cells via inhibition of cyclin-dependent kinases (CDKs)

Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia.

Deciphering the Therapeutic Potential of Novel Pentyloxyamide-Based Class I, IIb HDAC Inhibitors against Therapy-Resistant Leukemia

Targeting mitochondrial metabolism by the mitotoxin bromoxib in leukemia and lymphoma cells

A brain organoid/ALL co-culture model reveals the AP-1 pathway as critically associated with CNS involvement of BCP-ALL.

Synergistic drug interactions of the histone deacetylase inhibitor givinostat (ITF2357) in CRLF2-rearranged pediatric B-cell precursor Acute Lymphoblastic Leukemia identified by high-throughput drug screening

Collaborators (16)

Christoph Hieber

Andrea Hanel

Thomas Kurz

Oliver H. Krämer

Jolanda Sarno

Claire G Salter

Finn Kristian Hansen

Manuel Etzkorn

Sabine Strehl

Silvia von Karstedt

Vanna Denti

Maxmilian Seidl

Karina Stephanie Krings

Anke Katharina Bergmann

hans neubauer

christoph peter

Make your next move.